December 2025 exceptional surveillance of headaches in over 12s: diagnosis and management (NICE guideline CG150)
In December 2025, we reviewed the recommendations on management.
Surveillance decision
We will update this guideline. The update will focus on prophylactic treatment for migraine with or without aura to include candesartan.
This page was last updated: